SCHEMBL723041

SCHEMBL723041

Brc1ccc2ccc3c4ccccc4ccc3c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 4/20 0.64
ALDH1A1 P00352 3/20 0.58
HSD17B10 Q99714 3/20 0.58
HIF1A Q16665 1/20 0.58
CYP1B1 Q16678 1/20 0.58
CYP2A6 P11509 2/20 0.56
TSHR P16473 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
PAX8 Q06710 1/20 0.46
CYP1A2 P05177 2/20 0.44
HPGD P15428 1/20 0.44
POLB P06746 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31266523 0.95 ALDH1A1 (0.64) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL1527465 0.95 ALDH1A1 (0.64) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL18646836 0.91 HPRT1 (0.64) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL4354069 0.88 CYP2A6 (0.65) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL27766389 0.85 TRPM4 (0.57) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL15636102 0.85 CYP2A6 (0.55) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL19397097 0.84 CYP2A6 (0.58) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL14353625 0.83 CYP2A6 (0.50) HPRT1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL16076434 0.83 MEN1 (0.52) HPRT1ALDH1A1CYP2A6TDP1MEN1
SCHEMBL21764548 0.83 MEN1 (0.52) HPRT1ALDH1A1CYP2A6TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025089913-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME 덕산네오룩스 주식회사 2025-05-01 WO disclosed
US-20230380267-A1 COMPOUNDS FOR STRUCTURING FUNCTIONAL LAYERS OF ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-11-23 US disclosed
US-20230371363-A1 COMPOUNDS THAT CAN BE USED FOR STRUCTURING FUNCTIONAL LAYERS OF ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-11-16 US disclosed
EP-2609640-B1 PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION DU PONT (US) 2015-11-25 EP disclosed
EP-2609640-B1 PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION DU PONT (US) 2015-11-25 EP disclosed
US-8968883-B2 Chrysene derivative materials E I DU PONT DE NEMOURS AND COMPANY (US) 2015-03-03 US disclosed
US-8968883-B2 Chrysene derivative materials E I DU PONT DE NEMOURS AND COMPANY (US) 2015-03-03 US disclosed
US-8968883-B2 Chrysene derivative materials E I DU PONT DE NEMOURS AND COMPANY (US) 2015-03-03 US disclosed
US-8617720-B2 Electroactive composition and electronic device made with the composition E I DU PONT DE NEMOURS AND COMPANY (US) 2013-12-31 US disclosed
US-20130187140-A1 CHRYSENE DERIVATIVE MATERIALS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-07-25 US disclosed
US-20110147718-A1 ELECTROACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-23 US disclosed
US-20110147718-A1 ELECTROACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-23 US disclosed
US-20110147718-A1 ELECTROACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-23 US disclosed
US-20110037381-A1 CHRYSENE DERIVATIVE MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-17 US disclosed
US-20110037381-A1 CHRYSENE DERIVATIVE MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-17 US disclosed
US-20110037381-A1 CHRYSENE DERIVATIVE MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-17 US disclosed
WO-2011019360-A1 CHRYSENE DERIVATIVE MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-17 WO disclosed
WO-2011019360-A1 CHRYSENE DERIVATIVE MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-17 WO disclosed
US-20110037056-A1 PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-17 US disclosed
WO-2010068865-A2 PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037381-A1 CHRYSENE DERIVATIVE MATERIALS RIF1, CCNL2, ARL1 HPRT1 3889/4885ALDH1A1 766/4885HSD17B10 2078/4885
US-20230371363-A1 COMPOUNDS THAT CAN BE USED FOR STRUCTURING FUNCTIONAL LAYERS OF ORGANIC ELECTROLUMINESCENT DEVICES EPCAM, SELE, CTCF HPRT1 1496/4885ALDH1A1 705/4885HSD17B10 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.